CMES2 Applying the Evidence for GLP-1 Receptor Agonists in Type 2 Diabetes: Practice Perspectives

Program: CMES Ancillary Events
Clinical Session
Friday, March 6, 2015: 5:45 AM-8:00 AM
Sapphire B (Hilton San Diego Bayfront)
**This session is eligible for CME credit**

Supported by an educational grant from AstraZeneca

Upon completion of this educational activity, participants will be better able to:

  • Evaluate the most recent evidence when considering use of a GLP-1 RA as part of a type 2 diabetes mellitus (T2DM) treatment plan
  • Review updated safety data for the GLP-1 RA drug class
  • Discuss the nonglycemic effects of GLP-1 RAs, including their positive impact on weight and cardiovascular risk factors
  • Describe the optimal  use of GLP-1 RAs in the context of practice-based clinical scenarios

There is no cost to attend, however, seating is limited. Complimentary breakfast or dinner will be provided and all ENDO attendees are welcome. Priority seating will be given to Registration Ticket holders for the first 15 minutes after the advertised start time. If you have not been able to secure a Registration Ticket, the Endocrine Society will have a non-Ticket holder line for general admission to the session on a first-come, first-served basis. Register Now.

6:00 AM

Silvio E Inzucchi, MD, Section of Endocrinology, Yale School of Medicine, New Haven, CT
Disclosure: SEI: Planning Group Member, Merck & Co., Committee Member, Novo Nordisk, Scientific Board Member, Boehringer-Ingelheim, Research Materials, Takeda, Speaker, Astra Zeneca, Scientific Board Member, Eisai, Scientific Board Member, Lexicon Pharmaceuticals, Inc., Committee Member, Intarcia.
6:10 AM

Adrian Vella, MD, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN
Disclosure: AV: Consultant, Sanofi, Consultant, Genentech, Inc., Research Funding, Novartis Pharmaceuticals, Research Funding, BioKier.
6:35 AM

Anne L Peters, MD, Division of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, CA
Disclosure Not Provided: ALP
7:00 AM

Samuel Dagogo-Jack, MD, FRCP, University of Tennessee Health Science Center, Memphis, TN
Disclosure Not Provided: SD
See more of: CMES Ancillary Events